WASHINGTON, Sept 29 (Reuters) - Taking GlaxoSmithKline Plc’s (GSK.L: Quote, Profile, Research) Lamictal epilepsy drug during the first three months of pregnancy may increase the chances of having a baby with a cleft lip or palate, U.S. regulators warned on Friday.
